Tate & Lyle (LSE:TATE) sees earnings growth potential with new Manus alliance and dividend increase
Tate & Lyle (LSE:TATE) has recently confirmed its outlook for the fiscal year ending March 2025, maintaining expectations for steady revenue and EBITDA growth. The company has strategically partnered with Manus to enhance natural sweetener solutions, alongside announcing an increased interim dividend, reflecting its commitment to innovation and shareholder returns. In the following discussion, we will explore Tate & Lyle's competitive advantages, challenges, future prospects, and the market...